Abstract
AbstractThe use of light as a therapeutic agent has a long history. However, there is little or no scientific foundation for much of what has been published in the area of color therapy. There is a good foundation for the treatment of neonatal jaundice with blue light. Preliminary basic research suggests that when used with photodynamic agents, malignant tumors may be treatable with white light. Other studies suggest that psoriasis can be treated with ultraviolet light when the affected area is first covered with anthracene. Evidence is accumulating that shows how the human body does interact with light at a hormonal, metabolic, and endocrine level. I conclude that there has never been a better time for competent scientists to investigate whether there are additional effective color therapeutic procedures in addition to the use of blue light for jaundice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
